Dr. Patricia Larkin's career is dedicated to policy and regulatory assessments, focusing on the intersection of social determinants of health and health equity. Her expertise lies in managing human health and environmental risks, particularly in energy, water resources, and climate change. Patricia's research explores Canadian innovation in energy regulatory decision-making and its impact on risk management. She has led interdisciplinary international research projects, addressing risk management in public decision-making and environmental issues like carbon capture and storage. As Chair of the Applied Risk Management Specialty Group of the Society for Risk Analysis, she continues to contribute to this field.

Dr. Arnold, a former general surgeon and occupational health consultant in Labrador and Nouveau Quebec, served Quebec Cartier Mining Ltd and the Iron Ore Company of Canada from 1973 to 1981. He has held teaching positions at various Canadian medical faculties and currently serves as an Adjunct Professor at McGill University. Dr. Arnold earned his M.D. from Queen's University in 1968 and has an extensive publication and presentation record with over 100 papers. He has received numerous honors for his contributions to occupational health and workplace psychological health and safety.

Emma Hartnett is an internationally recognized expert in risk assessment, specializing in toxicological, microbiological, and nutritional hazards. She holds a B.Sc. in Microbiology and a Ph.D. in Statistics and Modelling Science, where her thesis work focused on quantitative risk assessment for campylobacter infection from chicken. Hartnett has developed a variety of decision support tools addressing issues from infectious diseases to bioterrorism preparedness. She frequently contributes to WHO and FAO initiatives, and has been selected for the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment Roster of Experts for 2018-2022.

Dr. Paul Stanish joined Risk Sciences International (RSI) in 2021 as a Risk Analyst, where he plays an essential role in advancing data-driven risk practices. Leveraging his strong background in chemistry and nanotechnology, he supports clients in building modern data cultures grounded in causal inference, machine learning operations (MLOps), and organizational performance measurement. His work ensures that risk frameworks not only incorporate emerging technologies but are also scalable and operational within institutional settings.

Dr. Nataliya Karyakina brings extensive expertise in toxicology and risk assessment to RSI. With a Ph.D. in Toxicology and experience at the McLaughlin Centre for Population Health Risk Assessment, she specializes in evaluating health risks from exposure to various toxic agents. Her research spans essential and toxic metals, pharmaceuticals, and nanomaterials. She has contributed to projects on chemical classification and labeling, as well as health-based regulatory guidance. Currently, she focuses on the health effects of engineered nanoalumina and diagnostic criteria for occupational manganism.

Dr. Anne Wiles joined Risk Sciences International (RSI) in 2008, where she currently serves as a Senior Analyst specializing in risk communication, perception, and governance. With a distinctive blend of expertise in language, regulation, and the use of science in decision-making, Anne has contributed to a wide range of RSI projects focused on the human and institutional dimensions of risk. Her work includes developing health risk communication strategies and drafting publicly accessible scientific information, advising on public messaging for nuclear energy and nuclear waste management, and supporting regulatory agencies in the evaluation and management of complex risk portfolios. She has been deeply involved in several RSI projects examining how mandates, institutional contexts, and public attitudes shape regulatory decision-making across federal domains. Anne has also contributed to scholarly work at RSI, including co-authoring a scoping review on the evolution of health and environmental risk decision-making, an article on the potential health risks associated with aluminum, and a book chapter on public concerns related to blood safety. In addition to her project work, Anne is a university instructor, teaching two courses: a broad overview of societal approaches to risk, and a graduate seminar on risk management in government, where she integrates academic theory with real-world regulatory case studies and risk communication practice.

With interdisciplinary training in Life Sciences, Public Health, and Public Administration, Dr. Michael G. Tyshenko specializes in health risk communication and policy. He collaborates globally on infectious disease research, including SARS, MERS, and COVID-19, and leads chemical peer reviews at Risk Sciences International (RSI). His work also extends to pandemic planning in Nepal, focusing on drone delivery of medical supplies to remote areas. Tyshenko's expertise is sought by various government departments in Canada and abroad.

Dr. Al-Zoughool, an associate professor at Kuwait University's College of Public Health, conducts interdisciplinary research on public health risks, including chemical, biological, physical, and lifestyle factors' impact on chronic diseases such as cancer and asthma. His work involves projects like modeling emerging infectious diseases, assessing occupational asthma in healthcare, and studying air pollution's cardiovascular disease risk. He previously held positions at King Saud Bin Abdulaziz University for Health Sciences, the University of Ottawa, and the International Agency for Research on Cancer. With 38 peer-reviewed articles, three book chapters, and extensive involvement in classifying human carcinogens, Dr. Al-Zoughool is a distinguished researcher in the field.

Dr. William Leiss held the NSERC/SSHRC Research Chair in Risk Communication and Public Policy at the Haskayne School of Business, University of Calgary, from 1999 to 2005. He has a substantial consulting background, collaborating with industry and various Canadian government departments on risk communication, risk management, public consultation, and multi-stakeholder consensus-building processes. Dr. Leiss has provided expertise on diverse issues, including pesticides, toxic chemicals, tobacco, prescription drugs, electric & magnetic fields, and genetic engineering. He earned his PhD from the University of California at San Diego.

With 20+ years experience in accounting and 12+ years experience in web development, I spend half of my time as a finance officer and bookkeeper. The other half of my time is spent coding, deploying, consulting and maintaining a variety of management web applications.